Search

everythinglearnresearchcommunity

for

Search:↓

Using the drugs AMD3100 and Tacrolimus together greatly improves skin healing and hair growth after a deep skin cut by increasing stem cells in the wound.

M50054 may help treat hepatitis and hair loss from chemotherapy.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

Recombinant thrombomodulin can effectively treat severe complications in Cronkhite-Canada syndrome.

CVP therapy showed moderate success in treating advanced non-Hodgkin's lymphoma, but more intensive treatment is needed for better outcomes.

Cyclosporin is effective for treating skin conditions in small animals, but requires careful dosing and monitoring for side effects.

Mononuclear cells may protect against certain chemotherapy-induced hair loss.

Cyclophosphamide can cause serious short-term and long-term side effects, including increased cancer risk and infertility.

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Oclacitinib effectively treated a diabetic cat's severe skin issues without raising glucose levels, and surgery fixed eyelid fusion.

Combining baricitinib with low-dose corticosteroids significantly improved severe hair loss in eight patients.

Intralesional cidofovir might be a good alternative treatment.

A young woman with a rare fungal infection showed significant improvement after treatment with antifungal medication.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

PPARγ signaling modulation can protect hair follicle stem cells from chemotherapy-induced damage.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Methotrexate is not proven effective for inducing remission in ulcerative colitis.

The folate-cyclodextrin conjugate targets cancer cells more precisely, potentially reducing chemotherapy side effects.

Lenalidomide helps hair follicle stem cells turn into melanocytes, which may improve repigmentation in vitiligo.

Using CDK inhibitors on rats showed a reduction in chemotherapy-caused hair loss, but later experiments could not repeat these results.

Tofacitinib taken by mouth helps treat hair loss in children.

The treatment significantly improved lymphocytic cicatricial alopecia symptoms in most patients.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Cell extracts may effectively and safely repair radiation-damaged salivary glands.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.